B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 41, 2011, Pages

  Scapini, Patrizia ^a,b   Lamagna, Chrystelle ^a   Hu, Yongmei ^a   Lee, Karim ^c   Tang, Qizhi ^c   DeFranco, Anthony L ^a   Lowell, Clifford A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B regulatory cells; Signal transduction; Tyrosine kinase

Indexed keywords

INTERLEUKIN 10; PROTEIN KINASE LYN; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; ENZYME DEFICIENCY; IMMUNOMODULATION; INFLAMMATORY DISEASE; LYMPHADENOPATHY; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; B-LYMPHOCYTES, REGULATORY; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHATIC DISEASES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELOID CELLS; SPLENOMEGALY; SRC-FAMILY KINASES; T-LYMPHOCYTES;

MUS;

EID: 80054743853     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1107913108     Document Type: Article

References (56)

1. Crispín JC, et al. (2010) Pathogenesis of human systemic lupus erythematosus: Recent advances. Trends Mol Med 16:47-57.
2. Jacob N, Stohl W (2010) Autoantibody-dependent and autoantibody- independent roles for B cells in systemic lupus erythematosus: Past, present, and future. Autoimmunity 43:84-97.
3. Crispín JC, Kyttaris VC, Terhorst C, Tsokos GC (2010) T cells as therapeutic targets in SLE. Nat Rev Rheumatol 6:317-325.
4. Katsiari CG, Liossis SN, Sfikakis PP (2010) The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: A reappraisal. Semin Arthritis Rheum 39:491-503.
5. Seitz HM, Matsushima GK (2010) Dendritic cells in systemic lupus erythematosus. Int Rev Immunol 29:184-209.
6. Rönnblom L, Elkon KB (2010) Cytokines as therapeutic targets in SLE. Nat Rev Rheumatol 6:339-347.
7. Richez C, Blanco P, Rifkin I, Moreau JF, Schaeverbeke T (2011) Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus. Joint Bone Spine 78:124-130.
8. Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6:823-835.
9. Morel L (2010) Genetics of SLE: Evidence from mouse models. Nat Rev Rheumatol 6: 348-357.
10. Xu Y, Harder KW, Huntington ND, Hibbs ML, Tarlinton DM (2005) Lyn tyrosine kinase: Accentuating the positive and the negative. Immunity 22:9-18. (Pubitemid 40143447)
11. Scapini P, Pereira S, Zhang H, Lowell CA (2009) Multiple roles of Lyn kinase in myeloid cell signaling and function. Immunol Rev 228:23-40.
12. Lu R, et al.; BIOLUPUS and GENLES Multicenter Collaborations (2009) Genetic associations of LYN with systemic lupus erythematosus. Genes Immun 10:397-403.
13. Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA (1997) Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7:69-81. (Pubitemid 27357266)
14. Scapini P, et al. (2010) Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J Exp Med 207:1757-1773.
15. Charles N, Hardwick D, Daugas E, Illei GG, Rivera J (2010) Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 16:701-707.
16. Sabat R, et al. (2010) Biology of interleukin-10. Cytokine Growth Factor Rev 21: 331-344.
17. Mosser DM, Zhang X (2008) Interleukin-10: New perspectives on an old cytokine. Immunol Rev 226:205-218.
18. Saraiva M, O'Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181.
19. Beebe AM, Cua DJ, de Waal Malefyt R (2002) The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13:403-412.
20. Llorente L, Richaud-Patin Y (2003) The role of interleukin-10 in systemic lupus erythematosus. J Autoimmun 20:287-289. (Pubitemid 36677520)
21. Maynard CL, Weaver CT (2008) Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol Rev 226:219-233.
22. Campbell DJ, Koch MA (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11:119-130.
23. Murai M, et al. (2009) Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10:1178-1184.
24. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA (2009) Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol 21:281-285.
25. Wan YY, Flavell RA (2007) Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445:766-770. (Pubitemid 46279706)
26. Zhou X, et al. (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10:1000-1007.
27. Horwitz DA (2008) Regulatory T cells in systemic lupus erythematosus: past, present and future. Arthritis Res Ther 10:227.
28. Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI (2006) Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 177:1451-1459. (Pubitemid 44092478)
29. DiLillo DJ, Matsushita T, Tedder TF (2010) B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 1183:38-57.
30. Lampropoulou V, et al. (2010) Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol Rev 233:146-161.
31. Mauri C, Blair PA (2010) Regulatory B cells in autoimmunity: Developments and controversies. Nat Rev Rheumatol 6:636-643.
32. Neves P, et al. (2010) Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33:777-790.
33. Blair PA, et al. (2009) Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 182:3492-3502.
34. Haas KM, et al. (2010) Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol 184:4789-4800.
35. Watanabe R, et al. (2010) Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 184:4801-4809.
36. Tsantikos E, et al. (2010) Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J Immunol 184:1348-1360.
37. Tsantikos E, et al. (2009) Perturbation of the CD4 T cell compartment and expansion of regulatory T cells in autoimmune-prone Lyn-deficient mice. J Immunol 183: 2484-2494.
38. Kamanaka M, et al. (2006) Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25:941-952. (Pubitemid 44894945)
39. Madan R, et al. (2009) Nonredundant roles for B cell-derived IL-10 in immune counterregulation. J Immunol 183:2312-2320.
40. Tang Q, et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199:1455-1465. (Pubitemid 38780401)
41. Yap DY, Lai KN (2010) Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: From basics to recent advances. J Biomed Biotechnol 2010:365083.
42. Damsker JM, Hansen AM, Caspi RR (2010) Th1 and Th17 cells: Adversaries and collaborators. Ann N Y Acad Sci 1183:211-221.
43. Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033-1036. (Pubitemid 36222922)
44. Yang XO, et al. (2008) Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29:44-56.
45. Yin Z, et al. (2002) IL-10 regulates murine lupus. J Immunol 169:2148-2155. (Pubitemid 34857682)
46. Blenman KR, et al. (2006) IL-10 regulation of lupus in the NZM2410 murine model. Lab Invest 86:1136-1148. (Pubitemid 44624150)
47. Ishida H, et al. (1994) Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310. (Pubitemid 24012996)
48. Lemoine S, Morva A, Youinou P, Jamin C (2009) Regulatory B cells in autoimmune diseases: How do they work? Ann N Y Acad Sci 1173:260-267.
49. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF (2009) The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 182:7459-7472.
50. Evans JG, et al. (2007) Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 178:7868-7878. (Pubitemid 46898059)
51. Leung S, et al. (2010) The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol 7:182-189.
52. Littman DR, Rudensky AY (2010) Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140:845-858.
53. Blair PA, et al. (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32:129-140.
54. Iwata Y, et al. (2010) Characterization of a rare IL-10-competent B-cell subset in man that parallels mouse regulatory B10 cells. Blood 117:530-541.
55. Zhang B, Zhang X, Tang F, Zhu L, Liu Y (2008) Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol 153:182-187. (Pubitemid 351989160)
56. Pereira S, Lowell C (2003) The Lyn tyrosine kinase negatively regulates neutrophil integrin signaling. J Immunol 171:1319-1327. (Pubitemid 36900063)